Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1095

1.

Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice.

Takeuchi H, Imamura K, Ji B, Tsukita K, Enami T, Takao K, Miyakawa T, Hasegawa M, Sahara N, Iwata N, Inoue M, Hara H, Tabira T, Ono M, Trojanowski JQ, Lee VM, Takahashi R, Suhara T, Higuchi M, Inoue H.

NPJ Vaccines. 2020 Mar 24;5:28. doi: 10.1038/s41541-020-0172-y. eCollection 2020.

2.

Vortioxetine vs. Placebo in Major Depressive Disorder: A Systematic Review and Meta-analysis of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in Japan.

Kishi T, Sakuma K, Okuya M, Matsuda Y, Iwata N.

Psychiatry Clin Neurosci. 2020 Mar 16. doi: 10.1111/pcn.13001. [Epub ahead of print] No abstract available.

PMID:
32175646
3.

Effect of Small Focus on Electron Heating and Proton Acceleration in Ultrarelativistic Laser-Solid Interactions.

Dover NP, Nishiuchi M, Sakaki H, Kondo K, Alkhimova MA, Faenov AY, Hata M, Iwata N, Kiriyama H, Koga JK, Miyahara T, Pikuz TA, Pirozhkov AS, Sagisaka A, Sentoku Y, Watanabe Y, Kando M, Kondo K.

Phys Rev Lett. 2020 Feb 28;124(8):084802. doi: 10.1103/PhysRevLett.124.084802.

PMID:
32167312
4.

Association between dry eye and depressive symptoms: Large-scale crowdsourced research using the DryEyeRhythm iPhone application.

Inomata T, Iwagami M, Nakamura M, Shiang T, Fujimoto K, Okumura Y, Iwata N, Fujio K, Hiratsuka Y, Hori S, Tsubota K, Dana R, Murakami A.

Ocul Surf. 2020 Feb 27. pii: S1542-0124(20)30026-4. doi: 10.1016/j.jtos.2020.02.007. [Epub ahead of print]

PMID:
32113987
5.

Petapascal Pressure Driven by Fast Isochoric Heating with a Multipicosecond Intense Laser Pulse.

Matsuo K, Higashi N, Iwata N, Sakata S, Lee S, Johzaki T, Sawada H, Iwasa Y, Law KFF, Morita H, Ochiai Y, Kojima S, Abe Y, Hata M, Sano T, Nagatomo H, Sunahara A, Morace A, Yogo A, Nakai M, Sakagami H, Ozaki T, Yamanoi K, Norimatsu T, Nakata Y, Tokita S, Kawanaka J, Shiraga H, Mima K, Azechi H, Kodama R, Arikawa Y, Sentoku Y, Fujioka S.

Phys Rev Lett. 2020 Jan 24;124(3):035001. doi: 10.1103/PhysRevLett.124.035001.

PMID:
32031862
6.

Comparison of corneal thickness in patients with dry eye disease using the Pentacam rotating Scheimpflug camera and anterior segment optical coherence tomography.

Fujimoto K, Inomata T, Okumura Y, Iwata N, Fujio K, Eguchi A, Nagino K, Shokirova H, Karasawa M, Murakami A.

PLoS One. 2020 Feb 3;15(2):e0228567. doi: 10.1371/journal.pone.0228567. eCollection 2020.

7.

Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis.

Kishi T, Ikuta T, Matsuda Y, Sakuma K, Iwata N.

Psychopharmacology (Berl). 2020 Jan 30. doi: 10.1007/s00213-020-05472-5. [Epub ahead of print]

PMID:
32002559
8.

Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers.

Okita K, Okazaki S, Uejima S, Yamada E, Kaminaka H, Kondo M, Ueda S, Tokiwa R, Iwata N, Yamasaki A, Hayashi N, Ogura D, Hirotani K, Yoshioka T, Inoue M, Masuko K, Masuko T.

Oncotarget. 2020 Jan 7;11(1):31-45. doi: 10.18632/oncotarget.27414. eCollection 2020 Jan 7.

9.

Blonanserin patch vs. Other Antipsychotics for Acute Schizophrenia: A Systematic Review of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in Japan.

Kishi T, Yoshimura R, Matsuda Y, Sakuma K, Iwata N.

Pharmacopsychiatry. 2020 Jan 30. doi: 10.1055/a-1096-1266. [Epub ahead of print]

PMID:
32000271
10.

Efficacy and Safety of Psychostimulants for Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Kishi T, Sakuma K, Iwata N.

Pharmacopsychiatry. 2020 Jan 30. doi: 10.1055/a-1076-8228. [Epub ahead of print]

PMID:
32000270
11.

Utility of the sleep stage sequence preceding sleep onset REM periods for the diagnosis of narcolepsy: a study in a Japanese cohort.

Kawai R, Watanabe A, Fujita S, Hirose M, Esaki Y, Arakawa C, Iwata N, Kitajima T.

Sleep Med. 2019 Apr 26;68:9-17. doi: 10.1016/j.sleep.2019.04.008. [Epub ahead of print]

PMID:
31999982
12.

Galectin 3-binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein.

Seki T, Kanagawa M, Kobayashi K, Kowa H, Yahata N, Maruyama K, Iwata N, Inoue H, Toda T.

J Biol Chem. 2020 Mar 13;295(11):3678-3691. doi: 10.1074/jbc.RA119.008703. Epub 2020 Jan 29.

13.

Human leukocyte antigen DRB1*04:05 and clozapine-induced agranulocytosis/granulocytopenia.

Saito T, Ikeda M, Mushiroda T, Iwata N; Clozapine Pharmacogenomics Consortium of Japan (CPC-J).

Aust N Z J Psychiatry. 2020 Jan 22:4867419900296. doi: 10.1177/0004867419900296. [Epub ahead of print] No abstract available.

PMID:
31968985
14.

GWAS of 165,084 Japanese individuals identified nine loci associated with dietary habits.

Matoba N, Akiyama M, Ishigaki K, Kanai M, Takahashi A, Momozawa Y, Ikegawa S, Ikeda M, Iwata N, Hirata M, Matsuda K, Murakami Y, Kubo M, Kamatani Y, Okada Y.

Nat Hum Behav. 2020 Mar;4(3):308-316. doi: 10.1038/s41562-019-0805-1. Epub 2020 Jan 20.

PMID:
31959922
15.

Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series.

Kamei H, Yamada H, Hatano M, Hanya M, Yamada S, Iwata N.

Clin Psychopharmacol Neurosci. 2020 Feb 29;18(1):159-163. doi: 10.9758/cpn.2020.18.1.159.

16.

Acceptance of the Deltoid Muscle Injection of Aripiprazole Long-acting Injectable in the Patients with Schizophrenia.

Kamei H, Homma Y, Takeuchi I, Hajitsu G, Tozawa K, Hatano M, Fukui A, Hanya M, Yamada S, Iwata N.

Clin Psychopharmacol Neurosci. 2020 Feb 29;18(1):49-57. doi: 10.9758/cpn.2020.18.1.49.

17.

Clinical practice guidance for juvenile dermatomyositis (JDM) 2018-Update.

Kobayashi I, Akioka S, Kobayashi N, Iwata N, Takezaki S, Nakaseko H, Sato S, Nishida Y, Nozawa T, Yamasaki Y, Yamazaki K, Arai S, Nishino I, Mori M.

Mod Rheumatol. 2020 Feb 3:1-13. doi: 10.1080/14397595.2020.1718866. [Epub ahead of print]

PMID:
31955618
18.

Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Shimizu M, Mizuta M, Okamoto N, Yasumi T, Iwata N, Umebayashi H, Okura Y, Kinjo N, Kubota T, Nakagishi Y, Nishimura K, Mohri M, Yashiro M, Yasumura J, Wakiguchi H, Mori M.

Pediatr Rheumatol Online J. 2020 Jan 10;18(1):2. doi: 10.1186/s12969-020-0399-1.

19.

A Single Medical Marker for Diagnosis of Methamphetamine Addiction - DNA Methylation of SHATI/NAT8L Promoter Sites from Patient Blood.

Yuka K, Nishizawa D, Hasegawa J, Uno K, Miyanishi H, Ujike H, Ozaki N, Inada T, Iwata N, Sora I, Iyo M, Yamada M, Kondo N, Won MJ, Naruse N, Uehara-Aoyama K, Ikeda K, Nitta A.

Curr Pharm Des. 2020;26(2):260-264. doi: 10.2174/1381612826666200110111703.

PMID:
31924153
20.

Activity-dependent cleavage of dyskinesia-related proline-rich transmembrane protein 2 (PRRT2) by calpain in mouse primary cortical neurons.

Hatta D, Shirotani K, Hori Y, Kurotaki N, Iwata N.

FASEB J. 2020 Jan;34(1):180-191. doi: 10.1096/fj.201902148R. Epub 2019 Nov 20.

PMID:
31914621
21.

Global DNA hypomethylation and its correlation to the betaine level in peripheral blood of patients with schizophrenia.

Murata Y, Ikegame T, Koike S, Saito T, Ikeda M, Sasaki T, Iwata N, Kasai K, Bundo M, Iwamoto K.

Prog Neuropsychopharmacol Biol Psychiatry. 2020 Apr 20;99:109855. doi: 10.1016/j.pnpbp.2019.109855. Epub 2020 Jan 3.

PMID:
31911076
22.

Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study.

Iwata N, Ishigooka J, Naoi I, Matsumoto M, Kanamori Y, Nakamura H, Higuchi T.

CNS Drugs. 2020 Jan;34(1):103-116. doi: 10.1007/s40263-019-00692-6.

23.

Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease: A Postmarketing Surveillance in Japan (SAKURA Study).

Miura M, Kobayashi T, Igarashi T, Hamada H, Iwata N, Sasaki Y, Matsukawa M, Sato N, Kubo H, Takei S.

Pediatr Infect Dis J. 2020 Jan;39(1):41-47. doi: 10.1097/INF.0000000000002503.

PMID:
31815838
24.

Characteristics and Risk Factors Associated With Diagnosed and Undiagnosed Symptomatic Dry Eye Using a Smartphone Application.

Inomata T, Iwagami M, Nakamura M, Shiang T, Yoshimura Y, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Hori S, Hiratsuka Y, Uchino M, Tsubota K, Dana R, Murakami A.

JAMA Ophthalmol. 2019 Nov 27. doi: 10.1001/jamaophthalmol.2019.4815. [Epub ahead of print]

PMID:
31774457
25.

Reliability and validity of the Japanese version of the Ocular Surface Disease Index for dry eye disease.

Midorikawa-Inomata A, Inomata T, Nojiri S, Nakamura M, Iwagami M, Fujimoto K, Okumura Y, Iwata N, Eguchi A, Hasegawa H, Kinouchi H, Murakami A, Kobayashi H.

BMJ Open. 2019 Nov 25;9(11):e033940. doi: 10.1136/bmjopen-2019-033940.

26.

Comparative genetic architectures of schizophrenia in East Asian and European populations.

Lam M, Chen CY, Li Z, Martin AR, Bryois J, Ma X, Gaspar H, Ikeda M, Benyamin B, Brown BC, Liu R, Zhou W, Guan L, Kamatani Y, Kim SW, Kubo M, Kusumawardhani AAAA, Liu CM, Ma H, Periyasamy S, Takahashi A, Xu Z, Yu H, Zhu F; Schizophrenia Working Group of the Psychiatric Genomics Consortium; Indonesia Schizophrenia Consortium; Genetic REsearch on schizophreniA neTwork-China and the Netherlands (GREAT-CN), Chen WJ, Faraone S, Glatt SJ, He L, Hyman SE, Hwu HG, McCarroll SA, Neale BM, Sklar P, Wildenauer DB, Yu X, Zhang D, Mowry BJ, Lee J, Holmans P, Xu S, Sullivan PF, Ripke S, O'Donovan MC, Daly MJ, Qin S, Sham P, Iwata N, Hong KS, Schwab SG, Yue W, Tsuang M, Liu J, Ma X, Kahn RS, Shi Y, Huang H.

Nat Genet. 2019 Dec;51(12):1670-1678. doi: 10.1038/s41588-019-0512-x. Epub 2019 Nov 18.

PMID:
31740837
27.

Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control study.

Igeta H, Watanabe Y, Morikawa R, Ikeda M, Otsuka I, Hoya S, Koizumi M, Egawa J, Hishimoto A, Iwata N, Someya T.

Neuropsychiatr Dis Treat. 2019 Aug 19;15:2353-2363. doi: 10.2147/NDT.S218773. eCollection 2019.

28.

A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder.

Katsuki A, Kakeda S, Watanabe K, Igata R, Otsuka Y, Kishi T, Nguyen L, Ueda I, Iwata N, Korogi Y, Yoshimura R.

Neuropsychiatr Dis Treat. 2019 Aug 23;15:2425-2432. doi: 10.2147/NDT.S204461. eCollection 2019.

29.

Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites.

Yoshimura R, Kishi T, Iwata N.

Neuropsychiatr Dis Treat. 2019 Sep 13;15:2655-2661. doi: 10.2147/NDT.S195379. eCollection 2019.

30.

Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study.

Iwata N, Ishigooka J, Kim WH, Yoon BH, Lin SK, Sulaiman AH, Cosca R, Wang L, Suchkov Y, Agarkov A, Watabe K, Matsui T, Sato T, Inoue Y, Higuchi T, Correll CU, Kane JM.

Schizophr Res. 2020 Jan;215:408-415. doi: 10.1016/j.schres.2019.07.055. Epub 2019 Aug 27.

31.

Polygenic risk scores in schizophrenia with clinically significant copy number variants.

Taniguchi S, Ninomiya K, Kushima I, Saito T, Shimasaki A, Sakusabe T, Momozawa Y, Kubo M, Kamatani Y, Ozaki N, Ikeda M, Iwata N.

Psychiatry Clin Neurosci. 2020 Jan;74(1):35-39. doi: 10.1111/pcn.12926. Epub 2019 Sep 30.

32.

The schizophrenia genetics knowledgebase: a comprehensive update of findings from candidate gene studies.

Liu C, Kanazawa T, Tian Y, Mohamed Saini S, Mancuso S, Mostaid MS, Takahashi A, Zhang D, Zhang F, Yu H, Doo Shin H, Sub Cheong H, Ikeda M, Kubo M, Iwata N, Woo SI, Yue W, Kamatani Y, Shi Y, Li Z, Everall I, Pantelis C, Bousman C.

Transl Psychiatry. 2019 Aug 27;9(1):205. doi: 10.1038/s41398-019-0532-4.

33.

Antidepressant-Like Effect of Ferulic Acid via Promotion of Energy Metabolism Activity.

Sasaki K, Iwata N, Ferdousi F, Isoda H.

Mol Nutr Food Res. 2019 Oct;63(19):e1900327. doi: 10.1002/mnfr.201900327. Epub 2019 Aug 22.

34.

Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis.

Kishi T, Sakuma K, Nomura I, Matsuda Y, Mishima K, Iwata N.

Int J Neuropsychopharmacol. 2019 Nov 1;22(11):698-709. doi: 10.1093/ijnp/pyz040.

35.

Light exposure at night and sleep quality in bipolar disorder: The APPLE cohort study.

Esaki Y, Kitajima T, Obayashi K, Saeki K, Fujita K, Iwata N.

J Affect Disord. 2019 Oct 1;257:314-320. doi: 10.1016/j.jad.2019.07.031. Epub 2019 Jul 5.

PMID:
31302520
36.

[Nursing Care Students' Image of Shame -Comparison Between First and Second Year Nursing Students].

Tsuji K, Iwata N, Simojo M, Hagiwara T, Sasaki Y, Nagata Y, Matsumoto M, Kodama H.

J UOEH. 2019;41(2):203-209. doi: 10.7888/juoeh.41.203. Japanese.

37.

Quetiapine extended-release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis.

Kishi T, Ikuta T, Matsuda Y, Iwata N.

Neuropsychopharmacol Rep. 2019 Sep;39(3):256-259. doi: 10.1002/npr2.12070. Epub 2019 Jul 8.

38.

Suvorexant for insomnia in patients with psychiatric disorder: A 1-week, open-label study.

Kishi T, Sakuma K, Okuya M, Ninomiya K, Oya K, Kubo M, Matsui Y, Nomura I, Okuyama Y, Matsunaga S, Iwata N.

Neuropsychopharmacol Rep. 2019 Sep;39(3):252-255. doi: 10.1002/npr2.12069. Epub 2019 Jul 8.

39.

Enhancing laser beam performance by interfering intense laser beamlets.

Morace A, Iwata N, Sentoku Y, Mima K, Arikawa Y, Yogo A, Andreev A, Tosaki S, Vaisseau X, Abe Y, Kojima S, Sakata S, Hata M, Lee S, Matsuo K, Kamitsukasa N, Norimatsu T, Kawanaka J, Tokita S, Miyanaga N, Shiraga H, Sakawa Y, Nakai M, Nishimura H, Azechi H, Fujioka S, Kodama R.

Nat Commun. 2019 Jul 5;10(1):2995. doi: 10.1038/s41467-019-10997-1.

40.

Daytime light exposure in daily life and depressive symptoms in bipolar disorder: A cross-sectional analysis in the APPLE cohort.

Esaki Y, Kitajima T, Obayashi K, Saeki K, Fujita K, Iwata N.

J Psychiatr Res. 2019 Sep;116:151-156. doi: 10.1016/j.jpsychires.2019.06.010. Epub 2019 Jun 17.

PMID:
31247358
41.

COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder.

Otsuka Y, Kakeda S, Sugimoto K, Katsuki A, Nguyen LH, Igata R, Watanabe K, Ueda I, Kishi T, Iwata N, Korogi Y, Yoshimura R.

Neuropsychiatr Dis Treat. 2019 Jun 6;15:1537-1545. doi: 10.2147/NDT.S199598. eCollection 2019.

42.

Melatonin receptor agonists-ramelteon and melatonin-for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.

Kishi T, Nomura I, Sakuma K, Kitajima T, Mishima K, Iwata N.

Neuropsychiatr Dis Treat. 2019 May 30;15:1479-1486. doi: 10.2147/NDT.S198899. eCollection 2019.

43.

Comparison of quetiapine immediate- and extended-release formulations for bipolar depression: A systematic review and network meta-analysis of double-blind, randomized placebo-controlled trials.

Kishi T, Ikuta T, Sakuma K, Matsuda Y, Iwata N.

J Psychiatr Res. 2019 Aug;115:121-128. doi: 10.1016/j.jpsychires.2019.05.020. Epub 2019 May 20.

PMID:
31128502
44.

Aminophospholipids are signal-transducing TREM2 ligands on apoptotic cells.

Shirotani K, Hori Y, Yoshizaki R, Higuchi E, Colonna M, Saito T, Hashimoto S, Saito T, Saido TC, Iwata N.

Sci Rep. 2019 May 17;9(1):7508. doi: 10.1038/s41598-019-43535-6.

45.

GWAS of smoking behaviour in 165,436 Japanese people reveals seven new loci and shared genetic architecture.

Matoba N, Akiyama M, Ishigaki K, Kanai M, Takahashi A, Momozawa Y, Ikegawa S, Ikeda M, Iwata N, Hirata M, Matsuda K, Kubo M, Okada Y, Kamatani Y.

Nat Hum Behav. 2019 May;3(5):471-477. doi: 10.1038/s41562-019-0557-y. Epub 2019 Mar 25.

PMID:
31089300
46.

Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study.

Hara R, Umebayashi H, Takei S, Okamoto N, Iwata N, Yamasaki Y, Nakagishi Y, Kizawa T, Kobayashi I, Imagawa T, Kinjo N, Amano N, Takahashi Y, Mori M, Itoh Y, Yokota S.

Pediatr Rheumatol Online J. 2019 Apr 30;17(1):17. doi: 10.1186/s12969-019-0319-4.

47.

Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design.

Oya K, Sakuma K, Esumi S, Hashimoto Y, Hatano M, Matsuda Y, Matsui Y, Miyake N, Nomura I, Okuya M, Iwata N, Kato M, Hashimoto R, Mishima K, Watanabe N, Kishi T.

Neuropsychopharmacol Rep. 2019 Sep;39(3):241-246. doi: 10.1002/npr2.12056. Epub 2019 Apr 26.

48.

Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ).

Yasumura J, Yashiro M, Okamoto N, Shabana K, Umebayashi H, Iwata N, Okura Y, Kubota T, Shimizu M, Tomiita M, Nakagishi Y, Nishimura K, Hara R, Mizuta M, Yasumi T, Yamaide F, Wakiguchi H, Kobayashi M, Mori M.

Pediatr Rheumatol Online J. 2019 Apr 11;17(1):15. doi: 10.1186/s12969-019-0318-5.

49.

Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms.

Kakeda S, Watanabe K, Katsuki A, Sugimoto K, Ueda I, Igata N, Kishi T, Iwata N, Abe O, Yoshimura R, Korogi Y.

Neuropsychiatr Dis Treat. 2019 Jan 29;15:375-383. doi: 10.2147/NDT.S190268. eCollection 2019.

50.

[The effectiveness of the complete lateral position method in elderly patients with severe dysphagia].

Kudo H, Ide H, Nakabayashi M, Goto T, Wakakuri A, Iwata N, Kuroki Y.

Nihon Ronen Igakkai Zasshi. 2019;56(1):59-66. doi: 10.3143/geriatrics.56.59. Japanese.

Supplemental Content

Support Center